Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?Positive | ||
Negative | ||
Uncertain | ||
Constraining | ||
Legalese | ||
Litigious | ||
Readability |
H.S. freshman Avg
|
New words:
abbreviated, abuse, addressed, AECB, ANDA, Androgen, Andrology, apnea, arbitration, article, assigned, attempt, attributable, audience, Auxilium, Auxilum, back, baseline, Beckman, Bentley, block, blood, book, breast, buccal, Bunt, called, card, cardiovascular, civil, Colangelo, component, congressional, controversy, Coulter, CPD, create, criminal, customary, DEA, demand, denial, deposit, directly, DPT, enlargement, Esq, expansion, experimental, export, FASB, female, fill, flouroquinolone, fluid, free, gathering, gel, governmental, handling, highest, hormone, hypogonadism, ICS, IIa, imposition, improper, IMS, inappropriate, inEndocrine, Journal, jurisdiction, lapse, listed, lowest, mandatory, maximum, mutually, naphythyridine, Nick, Noncompliance, opportunity, opposed, overhead, packaging, Paddock, patch, Patheon, payroll, pentadecalactone, permission, Pharmaco, physician, pneumococcal, Political, post, predetermined, procure, prostate, published, qualification, rebate, Receptor, red, refilled, refusal, regular, regulation, reliable, relocated, relocation, renew, rental, replace, replacement, replacing, request, retention, retrospective, revocation, saleable, salt, seizure, sleep, slightly, slower, software, Solvay, sperm, storage, sublease, suggested, supplier, suppression, suspension, tentative, Testim, testosterone, theInternational, therapy, threshold, timetable, Ton, topical, transdermal, TRT, unclaimed, undisclosed, unforeseen, uninterrupted, Vendor, viable, voluntary, voucher, Waltham, warehousing, warning, Watson, withdraw, withdrawal, withdrawn, write
Removed:
ABECB, achieving, administered, announcing, annum, applying, appraise, assume, asthma, astrazeneca, billing, bioequivalence, Biosearch, Biotech, bloodstream, borrowing, bridge, British, byHelicobacter, carrying, Chapter, Chemistry, closed, Clostridium, CMC, Code, collection, composed, comprising, consolidation, consummated, controlling, deemed, directed, disposal, enterococci, examine, externally, financed, fungal, furnished, gastrointestinal, genetic, Genome, herewith, incorporated, indefinite, industrial, initiative, Institute, intercompany, Italia, LIBOR, loan, long, measure, Mouse, nosocomial, orally, owed, performing, periodically, permanent, pertaining, pilot, pipeline, planned, plant, pylori, Rat, ratably, ratio, realized, reference, referenced, referred, release, relevant, restructure, retirement, role, spread, substantive, summary, Supplemental, supportive, thirty, track, treated, turned, twelve, unbilled, undergo, undiscounted, unrestricted, vacate, validated, valuation, Versicor, wholly
Filing tables
Filing exhibits
- 10-Q Quarterly report
- 10.1 Amendment No. 4 to License and Option Agreement Dated March 31, 2005
- 10.2 Co-promotion Agreement Dated April 11, 2005
- 31.1 Certification of Chief Executive Officer Pursuant to Section 302
- 31.2 Certification of Chief Financial Officer Pursuant to Section 302
- 32.1 Certification of Chief Executive Officer Pursuant to Section 906
- 32.2 Certification of Chief Financial Officer Pursuant to Section 906
Related press release
OSCI similar filings
Filing view
External links